[HTML][HTML] 最新产品价格查看产品价格
H Zegzouti, J Alves, T Worzella, G Vidugiris… - 2011 - promega.com.cn
Selectivity of a kinase inhibitor towards the target of interest is critical for its advancement
through the various phases of drug development. This makes kinase profiling of the inhibitor …
through the various phases of drug development. This makes kinase profiling of the inhibitor …
[HTML][HTML] Découvrez nos offres Promotions
H Zegzouti, J Alves, T Worzella, G Vidugiris… - 2011 - france.promega.com
Selectivity of a kinase inhibitor towards the target of interest is critical for its advancement
through the various phases of drug development. This makes kinase profiling of the inhibitor …
through the various phases of drug development. This makes kinase profiling of the inhibitor …
[HTML][HTML] Special Offers and Discounts View all promotions
H Zegzouti, J Alves, T Worzella, G Vidugiris… - 2011 - ita.promega.com
Selectivity of a kinase inhibitor towards the target of interest is critical for its advancement
through the various phases of drug development. This makes kinase profiling of the inhibitor …
through the various phases of drug development. This makes kinase profiling of the inhibitor …
[PDF][PDF] ADP-Glo™ Kinase Profiling Systems for targeted and flexible kinase inhibitor profiling
H Zegzouti, J Hennek, J Alves, S Goueli - 2014 - cdn.technologynetworks.com
Drug safety is of paramount importance in the pharmaceutical industry indicating that
minimal side effects constitute a major requirement in drug development. Therefore, novel …
minimal side effects constitute a major requirement in drug development. Therefore, novel …
Expanding the kinome inhibitor selectivity Atlas
D Auld - ASSAY and Drug Development Technologies, 2008 - go.gale.com
Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.
The biological consequences of multi-kinase activity are poorly defined, and an important …
The biological consequences of multi-kinase activity are poorly defined, and an important …
Developing assays for kinase drug discovery–where have the advances come from?
Over the past decade, a variety of technologies for the identification and characterization of
protein kinase inhibitors have been implemented in the laboratories of nearly every major …
protein kinase inhibitors have been implemented in the laboratories of nearly every major …
Protein Kinase Inhibitor Design and Screening-A GTCBIO conference. Philadelphia, Pennsylvania, USA-September 10-11, 2015
C Zhang - Drugs of the Future, 2015 - access.portico.org
SUMMARY GTCbio's Protein Kinase Inhibitor Design and Screening Meeting was one of six
co-located conferences at the Modern Drug Discovery and Development Summit, which …
co-located conferences at the Modern Drug Discovery and Development Summit, which …
[PDF][PDF] OUTSOURCED KINASE PROFILING SERVICES–
J Comley - Drug Discovery, 2013 - ddw-online.com
Biochemical kinase profiling using a large panel of kinases with a broad coverage of the
human kinome has become the de facto norm within the Pharma industry. The importance of …
human kinome has become the de facto norm within the Pharma industry. The importance of …
What general conclusions can we draw from kinase profiling data sets?
Understanding general selectivity trends across the kinome has implications ranging from
target selection, compound prioritization, toxicity and patient tailoring. Several recent …
target selection, compound prioritization, toxicity and patient tailoring. Several recent …
High throughput screening for protein kinase inhibitors
H Wesche, SH Xiao, SW Young - Combinatorial Chemistry & …, 2005 - ingentaconnect.com
The pivotal role of kinases in signal transduction and cellular regulation has lent them
considerable appeal as pharmacological targets across a broad spectrum of pathologies …
considerable appeal as pharmacological targets across a broad spectrum of pathologies …